Stents plus drugs vs. drugs alone: which is better for heart failure?
NCT ID NCT07349979
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two approaches for people with heart failure and narrowed heart arteries: a stent procedure plus guideline-directed medications versus medications alone. About 1,150 participants will be followed for at least two years to see which group has fewer major heart problems like heart attacks, hospitalizations, or death. The goal is to find out if adding a stent improves outcomes beyond what medications can achieve.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
heart stent procedure (percutaneous coronary intervention) plus standard heart failure medications
What this could lead to
If it works, this could show that combining stents with medications is better than medications alone for preventing heart attacks, hospitalizations, and death in people with heart failure.
What could go wrong
This trial hasn't started yet, so results are years away. The procedure carries risks like bleeding or vessel damage, and the benefit over medications alone may be small or absent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, 210006, China